The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers

European Journal of Anaesthesiology

Volumn 27, Issue 9, 2010, Pages 829-834

  Mizogami, Maki ^a   Takakura, Ko ^a   Tsuchiya, Hironori ^a  

^a ASAHI UNIVERSITY   (Japan)

Author keywords

Differential characterization; Hydrophobicity; Lipid bilayers; Membrane interactivity; Selective and nonselective 1 blockers

Indexed keywords

ALPRENOLOL; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPALMITOYLPHOSPHATIDYLCHOLINE; ESMOLOL; LIPOSOME; METOPROLOL; OXPRENOLOL; PROPRANOLOL;

ARTICLE; BIOMIMETICS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SELECTIVITY; FLUIDIZATION; FLUORESCENCE POLARIZATION; HYDROPHOBICITY; LIPID MEMBRANE; MEMBRANE FLUIDITY; PHOSPHOLIPID BILAYER; REVERSED PHASE LIQUID CHROMATOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; ALPRENOLOL; ANESTHESIA; ANESTHETICS; ATENOLOL; BIOMIMETICS; LIPID BILAYERS; LIPIDS; LIPOSOMES; MEMBRANES, ARTIFICIAL; METOPROLOL; OXPRENOLOL; PROPANOLAMINES; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA;

EID: 77956799413     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32833bf5e4     Document Type: Article

References (30)

1. Jakobsen CJ, Blom L. Effect of preoperative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. Eur J Anaesthesiol 1992; 9:209-215.
2. Auerbach AD, Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery. JAMA 2002; 287:1435-1444.
3. Lombaard SA, Robbertze R. Perioperative use of β-blockers in the elderly patient. Anesthesiol Clin 2009; 27:581-597.
4. Aronson JK. Changing beta-blockers in heart failure: when is a class not a class? Br J Gen Pract 2008; 58:387-389.
5. Lynch C III. Meyer and Overton revised. Anesth Analg 2008; 107:864-867.
6. Shi B, Tien HT. Action of calcium channel and p-adrenergic blocking agents in bilayer lipid membranes. Biochim Biophys Acta 1986; 24:125-134.
7. Varga E, Szollosi J, Antal K, et al. Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol. Pharmazie 1999; 54:380-384.
8. Butler S, Wang R, Wunder SL, et al. Perturbing effects of carvedilol on a model membrane system: role of lipophilicity and chemical structure. Biophys Chem 2006; 119:307-315.
9. Ma Z, LeeSS, Meddings JB. Effects of altered cardiac membrane fluidity on β-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy. J Hepatol 1997; 26:904-912.
10. Carda-Broch S, Berthod A. pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography. J Chromatogr A 2003; 995:55-66.
11. Detroyer A, Heyden YV, Carda-Broch S, et al. Quantitative structure- retention and retention-activity relationships of β-blocking agents by micellar liquid chromatography. J Chromatogr A 2001; 912: 211-221.
12. Mizogami M, Tsuchiya H, Ueno T, et al. Stereospecific interaction of bupivacaine enantiomers with lipid membranes. Reg Anesth Pain Med 2008; 33:304-311.
13. Tsuchiya H, Mizogami M, Takakura K. Reversed-phase liquid chromatographic retention and membrane activity relationships of local anesthetics. J Chromatogr A 2005; 1073:303-308.
14. Kraak JC, van Rooij HH, Thus JLG. Reversed-phase ion pair systems for the prediction of n-octanol-water partition coefficients of basic compounds by high-performance liquid chromatography. J Chromatogr A 1986; 352:455-463.
15. Tsuchiya H, Mizogami M. Membrane interactivity of charged local anesthetics derivative and stereoselectivity in membrane interaction of local anesthetic enantiomers. Local Reg Anesth 2008; 1:1-9.
16. Schroeder R, London E, Brown D. Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci USA 1994; 91:12130-12134.
17. Tsuchiya H. Structure-specific membrane-fluidizing effect of propranolol. Clin Exp Pharmacol Physiol 2001; 28:292-299.
18. Tsuchiya H, Nagayama M. Garlic allyl derivatives interact with membrane lipids to modify the membrane fluidity. J Biomed Sci 2008; 15:653-660.
19. Ondrias K, Stasko A, Jancinova V, Balgavy P. Comparison of the effect of eleven β-adrenoceptor blocking drugs in perturbing lipid membrane: an ESR spectroscopy study. Mol Pharmacol 1987; 31:97-102.
20. Repáková J, Holopainen JM, Morrow MR, et al. Influence of DPH on the structure and dynamics of a DPPC bilayer. Biophys J 2005; 88:3398-3410.
21. Cantor RS. Receptor desensitization by neurotransmitters in membranes: are neurotransmitters the endogenous anesthetics? Biochemistry 2003; 42:11891-11897.
22. 2-adrenoceptor agonists. J Med Chem 2003; 46:3210-3220.
23. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev MolCell Biol 2000; 1 :31-39.
24. 2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem 2002; 277:34280-34286.
25. Ianoul A, Grant DD, Rouleau Y, et al. Imaging nanometer domains of β-adrenergic receptor complexes on the surface of cardiac myocytes. Nat Chem Biol 2005; 1:196-202.
26. Hirata F, Axelrod J. Phospholipid methylation and biological signal transmission. Science 1980; 209:1082-1090.
27. Gazawi H, Ljubuncic P, Cogan U, et al. The effects of bile acids on β-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes. Biochem Pharmacol 2000; 59:1623-1628.
28. Lombardi D, Cuenoud B, Krämer SD. Lipid membrane interactions of indacaterol and salmetelol: do they influence their pharmacological properties? Eur J Pharm Sci 2009; 38:533-547.
29. Muller CP, Krueger GRF. Modulation of membrane proteins by vertical phase separation and membrane lipid fluidity. Basis for a new approach to tumor immunotherapy. Anticancer Res 1986; 6:1181-1194.
30. Yun I, Cho E-S, Jang H-O, et al. Amphiphilic effects of local anesthetics on rotational mobility in neuronal and model membranes. Biochim Biophys Acta 2002; 1564:123-132.